EIGHTCHECK-3WP X-TRA TM

HEMATOLOGY CONTROL
Insight Insight Insight
Expiration Date: 2010-11-03 Data Due Date #1: 30-Aug-10 Data Due Date #2: 02-Oct-10 Data Due Date #3: 03-Nov-10
Lot Number: 02080710 02080711 02080712
Control: Low Abnormal Normal High Abnormal

Parameters Mean Expected Range Mean Expected Range Mean Expected Range

SYSMEX KX-SERIES
3
WBC x10 /µL 3.0 2.5 - 3.4 7.1 6.4 - 7.9 18.2 16.4 - 20.0
RBC x106/µL 2.29 2.09 - 2.49 4.26 4.00 - 4.52 5.21 4.95 - 5.47
HGB g/dL 6.6 6.2 - 7.0 13.3 12.5 - 14.1 17.3 16.4 - 18.2
HCT % 17.4 15.9 - 18.9 34.6 32.2 - 37.0 44.9 41.3 - 48.5
MCV fL 76.0 63.9 - 90.4 81.2 71.3 - 92.5 86.2 75.5 - 98.0
MCH pg 28.8 24.9 - 33.5 31.2 27.7 - 35.2 33.2 30.0 - 36.7
MCHC g/dL 37.9 32.9 - 43.9 38.4 33.8 - 43.8 38.5 33.9 - 44.0
PLT x103/µL 49 33 - 65 206 169 - 243 487 424 - 550
Lymph (W-SCR) % 25.9 22.0 - 29.8 31.6 28.4 - 34.8 35.4 31.9 - 38.9
Mixed (W-MCR) % 9.8 5.4 - 14.2 10.8 8.1 - 13.5 15.9 13.2 - 18.6
Neut (W-LCR) % 64.3 59.2 - 69.4 57.6 54.1 - 61.1 48.7 44.8 - 52.6
Lymph (W-SCC) x103/µL 0.8 0.5 - 1.0 2.3 1.7 - 2.8 6.4 5.7 - 7.2
Mixed (W-MCC) x103/µL 0.3 0.1 - 0.4 0.8 0.6 - 1.0 2.9 2.3 - 3.5
Neut (W-LCC) x103/µL 1.9 1.5 - 2.3 4.1 3.5 - 4.7 8.9 7.8 - 9.9
RDW-CV % 10.2 8.6 - 11.8 9.3 7.7 - 10.9 9.6 7.9 - 11.3
RDW-SD fL 33.0 27.4 - 38.6 33.0 27.7 - 38.3 35.6 30.3 - 40.9
MPV fL 9.1 7.6 - 10.6 9.3 8.3 - 10.3 9.2 8.4 - 10.0
W-SMV fL 63.0 53.6 - 72.5 62.9 56.0 - 69.8 63.2 56.9 - 69.5
W-LMV fL 202.3 186.1 - 218.5 202.6 186.4 - 218.8 203.2 188.0 - 218.4

Please note: Remove vial cap before running QC Product

SYSMEX pocH-100i
WBC x103/µL 2.8 2.4 - 3.2 7.1 6.4 - 7.8 18.2 16.4 - 20.0
RBC x106/µL 2.37 2.16 - 2.58 4.42 4.15 - 4.69 5.34 5.07 - 5.61
HGB g/dL 6.3 6.0 - 6.6 13.0 12.4 - 13.7 17.0 16.3 - 17.7
HCT % 19.3 17.7 - 20.9 38.3 35.6 - 41.0 49.1 45.2 - 53.0
MCV fL 81.4 68.5 - 96.9 86.7 76.0 - 98.6 91.9 80.6 - 104.5
MCH pg 26.6 23.2 - 30.6 29.4 26.4 - 32.9 31.8 29.1 - 34.9
MCHC g/dL 32.6 28.6 - 37.5 33.9 30.1 - 38.3 34.6 30.8 - 39.1
PLT x103/µL 47 31 - 63 203 166 - 240 470 409 - 531
Lymph (W-SCR) % 24.8 21.1 - 28.5 31.2 28.1 - 34.3 35.8 32.2 - 39.4
Mixed (W-MCR) % 9.2 5.1 - 13.3 10.5 7.9 - 13.1 15.3 12.7 - 17.9
Neut (W-LCR) % 66.0 60.7 - 71.3 58.3 54.8 - 61.8 48.9 45.0 - 52.8
Lymph (W-SCC) x103/µL 0.7 0.5 - 0.9 2.2 1.7 - 2.8 6.5 5.7 - 7.3
Mixed (W-MCC) x103/µL 0.3 0.2 - 0.5 0.7 0.5 - 0.9 2.8 2.3 - 3.3
Neut (W-LCC) x103/µL 1.8 1.4 - 2.2 4.2 3.6 - 4.8 8.9 7.8 - 10.0
RDW-CV % 14.2 11.9 - 16.5 13.7 11.4 - 16.0 13.9 11.4 - 16.4
RDW-SD fL 40.8 33.9 - 47.7 41.9 35.2 - 48.6 45.0 38.3 - 51.8
MPV fL 10.1 8.5 - 11.7 9.9 8.8 - 11.0 9.7 8.8 - 10.6
W-SMV fL 64.2 48.2 - 80.3 64.0 49.9 - 78.1 63.8 51.0 - 76.6
W-LMV fL 204.9 184.4 - 225.4 204.7 184.2 - 225.2 204.7 184.2 - 225.2

Refer to package insert for Sysmex recommendations on setting QC targets and limits.

Distributed by: 350165

Sysmex America, Inc Rev 8. 06-Jan-10
Distributed by: Jul-10
 EIGHTCHECK-3WP X-TRA TM

HEMATOLOGY CONTROL
Insight Insight Insight
Expiration Date: 2010-11-03 Data Due Date #1: 30-Aug-10 Data Due Date #2: 02-Oct-10 Data Due Date #3: 03-Nov-10
Lot Number: 02080710 02080711 02080712
Control: Low Abnormal Normal High Abnormal

Parameters Mean Expected Range Mean Expected Range Mean Expected Range

SYSMEX K-4500, OPEN MODE

3
WBC x10 /µL 3.2 2.8 - 3.6 7.7 6.9 - 8.5 19.6 17.6 - 21.6
RBC x106/µL 2.31 2.17 - 2.45 4.38 4.18 - 4.58 5.26 5.00 - 5.52
HGB g/dL 6.4 6.1 - 6.7 13.3 12.8 - 13.8 17.1 16.4 - 17.8
HCT % 17.5 16.1 - 18.9 35.5 33.0 - 38.0 45.2 42.0 - 48.4
MCV fL
MCH pg
MCHC g/dL
O 75.8
27.7
36.6
65.8
24.9
32.2
-
-
-
87.0
30.9
41.7
81.1
30.4
37.5
72.1
28.0
33.8
-
-
-
90.8
32.9
41.7
85.9
32.5
37.8
76.1
29.7
33.9
-
-
-
96.8
35.6
42.3
PLT x103/µL
Lymph (W-SCR) %
Mixed (W-MCR) %
P 52
25.5
10.3
35
22.7
5.7
-
-
-
69
28.3
14.9
209
31.1
11.4
180
28.0
8.6
-
-
-
238
34.2
14.3
468
34.2
16.5
417
30.8
13.7
-
-
-
519
37.6
19.3
Neut (W-LCR) %
Lymph (W-SCC) x103/µL
Mixed (W-MCC) x103/µL
E 64.2
0.8
0.3
60.3
0.6
0.0
-
-
-
68.1
1.1
0.7
57.5
2.4
0.9
54.1
1.8
0.6
-
-
-
61.0
3.0
1.1
49.3
6.7
3.2
46.3
5.0
2.6
-
-
-
52.3
8.4
3.9
Neut (W-LCC) x103/µL
RDW-CV %
RDW-SD fL
N 2.1
10.6
24.2
1.7
8.9
20.1
-
-
-
2.4
12.3
28.3
4.4
10.0
25.3
4.0
8.3
21.3
-
-
-
4.9
11.7
29.3
9.7
10.3
28.8
8.9
8.4
24.5
-
-
-
10.4
12.2
33.1
MPV fL 9.1 8.1 - 10.1 9.2 8.5 - 9.9 9.2 8.4 - 10.0
W-SMV fL 57.7 52.5 - 62.9 57.8 52.6 - 63.0 58.7 53.4 - 64.0
W-LMV fL 200.7 184.6 - 216.8 201.0 184.9 - 217.1 202.9 187.7 - 218.1

SYSMEX K-4500, CLOSED MODE

WBC x103/µL 3.2 2.7 - 3.7 7.6 6.6 - 8.5 19.2 16.7 - 21.7

C
RBC x106/µL 2.33 2.19 - 2.47 4.34 4.12 - 4.56 5.21 4.92 - 5.50
HGB g/dL 6.4 6.0 - 6.8 13.2 12.7 - 13.7 16.9 16.1 - 17.7
HCT % 17.7 16.2 - 19.2 35.2 32.6 - 37.8 44.7 41.3 - 48.1

L
MCV fL 75.9 65.7 - 87.5 81.2 71.5 - 91.8 85.8 75.2 - 97.6
MCH pg 27.4 24.4 - 31.0 30.4 27.8 - 33.3 32.5 29.4 - 35.9
MCHC g/dL 36.2 31.4 - 41.8 37.4 33.5 - 42.2 37.9 33.6 - 42.7
PLT x103/µL
Lymph (W-SCR) %
Mixed (W-MCR) %
O 51
25.5
10.3
33
21.7
5.2
-
-
-
69
29.3
15.5
194
31.1
11.4
165
27.1
7.6
-
-
-
223
35.1
15.2
431
34.2
16.5
375
29.8
13.0
-
-
-
487
38.6
20.0
Neut (W-LCR) %
Lymph (W-SCC) x103/µL
Mixed (W-MCC) x103/µL
S 64.2
0.8
0.3
57.8
0.6
0.0
-
-
-
70.6
1.1
0.7
57.5
2.4
0.9
51.8
1.7
0.4
-
-
-
63.3
3.0
1.3
49.3
6.6
3.2
44.4
4.7
2.4
-
-
-
54.2
8.5
3.9
Neut (W-LCC) x103/µL
RDW-CV % E 2.1
10.6
24.2
1.6
8.9
20.1
-
-
-
2.5
12.3
28.3
4.3
10.0
25.3
3.7
8.3
21.3
-
-
-
4.9
11.7
29.3
9.5
10.3
28.8
8.3
8.4
24.5
-
-
-
10.6
12.2
33.1

D
RDW-SD fL
MPV fL 9.1 8.1 - 10.1 9.2 8.5 - 9.9 9.2 8.4 - 10.0
W-SMV fL 57.7 52.5 - 62.9 57.8 52.6 - 63.0 58.7 53.4 - 64.0
W-LMV fL 200.7 184.6 - 216.8 201.0 184.9 - 217.1 202.9 187.7 - 218.1

Refer to package insert for Sysmex recommendations on setting QC targets and limits.

Distributed by: 350165

Sysmex America, Inc. Rev 8. 06-Jan-10
Distributed by: Jul-10